Formulation and Characterization of Bioactive Agent Containing Nanodisks

Kyle Lethcoe; Colin A. Fox; Isabel Moh; Matthew Swackhamer; Michael Karo; Ryan Lockhart; Robert O. Ryan

doi:10.3791/65145

Journal

/

Biochemistry

/

Formulation and Characterization of Bioactive Agent Containing Nanodisks

JoVE Journal
Biochemistry

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biochemistry

Formulation and Characterization of Bioactive Agent Containing Nanodisks

860 Views

•

07:58 min

•

March 17, 2023

DOI:

10.3791/65145-v

DOI:

10.3791/65145-v

•

07:58 min

March 17, 2023

•

3 Views

Kyle Lethcoe¹, Colin A. Fox¹, Isabel Moh¹, Matthew Swackhamer¹, Michael Karo¹, Ryan Lockhart¹, Robert O. Ryan¹

¹Department of Biochemistry and Molecular Biology,University of Nevada

Summary

Here, we describe the production and characterization of bioactive agents containing nanodisks. Amphotericin B nanodisks are taken as an example to describe the protocol in a stepwise manner.

Explore More Videos

Nanodisks Bioactive Agents Formulation Characterization DMPC AmpB ApoE4 NT Dialysis Phospholipid Drug Delivery Aqueous Solubility Hydrophobic Compounds

Read Article

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Automatically Generated

Summary

Automatically generated

Explore More Videos